CNH Industrial: A Trough Priced at 31 Times Earnings That Normalizes to 11.5 Times, While Construction Earns a 2.3% Margin and Exor Holds 45.6% of the Vote

CNH's own inventory should also not be confused with dealer inventory. Consolidated inventory actually rose from $4.65 billion at December 2025 to $5.17 billion at June 2026, generating a $436 million operating-cash-flow outflow in the first half. Dealer inventory is downstream stock, much of it financed through floor-plan facilities, and can decline while CNH's seasonal factory inventory rises. Keeping the two apart matters most when judging whether the channel reset is actually complete.

A second reason reported margins sit so low is spending behavior. In 2025, SG&A increased to $1.876 billion from $1.712 billion even as industrial sales fell 10%, while R&D expense rose to $1.025 billion from $924 million. Industrial gross margin, approximated from net sales less cost of goods sold, fell from about 21.7% to 19.3%. In Q1 2026 Agriculture R&D reached 7.9% of sales versus 6.3% a year before; Q2 was 6.1%. So CNH has real operating leverage available when volumes recover, but management is also choosing to preserve technology investment through the trough.

My normalization does not assume a return to the exceptional 2023 peak. I use about $15.0 billion of mid-cycle Agriculture sales and an 11.5% adjusted EBIT margin, versus roughly $12.4 billion and 5.0–5.5% in 2026 guidance. Construction normalizes only to about $3.3 billion of sales and a 4.5% margin, well below what a high-quality machinery franchise would earn. After corporate costs, finance income and a normalized tax burden, this produces approximately $1.15–1.20 of mid-cycle adjusted EPS. At $13.48, that puts CNH on roughly 11–12 times my normalized earnings, not 31 times the trough. The stock is much cheaper than its headline multiple implies, but not automatically cheap enough to compensate for franchise and governance disadvantages.

The biggest structural disagreement is precision agriculture. One correction to a widely repeated confusion is important: PTx is AGCO's precision-agriculture architecture, not CNH's. CNH's current technology proposition is built around Raven, FieldOps and its subsequent sensing/GNSS capabilities. CNH does not disclose a stand-alone precision-agriculture revenue figure, operating margin, annual recurring revenue or software-subscription attach rate. That disclosure gap prevents investors from proving that the technology portfolio already possesses software-like economics. The $123 million non-cash impairment in Q4 2025 of in-process R&D acquired with Raven does not mean the $2-billion-plus Raven strategy failed, but it is a reason to demand evidence rather than capitalize a technology narrative on faith.

Against Deere, CNH's position remains second tier. Deere has the stronger North American large-ag dealer system, tighter machine-software-service integration, better demonstrated precision monetization and greater aftermarket economics. AGCO attacks from a different direction: its PTx strategy is designed around mixed-fleet retrofit and gives farmers an alternative to an entirely closed equipment ecosystem. CNH sits between those models. Its full-line scale and Raven capabilities are considerable, but FieldOps has yet to prove that it can create the same customer lock-in as Deere or the same clear mixed-fleet differentiation as AGCO. In my view, Deere retains the strongest long-run model, AGCO has the most differentiated open-system challenger proposition, and CNH currently ranks third in precision monetization.

Construction calls for a harder judgment still. Sales rose 12% in Q2, but adjusted EBIT margin fell to 1.7% from 4.5%. Full-year 2025 margin was only 2.3%, versus 5.5% in 2024; 2026 guidance is 1.8–2.3%. Management's disclosed plan is to improve quality, manufacturing efficiency and tariff offsets, not to exit the segment. At these margins, Construction probably does not earn CNH's cost of capital after assigning a reasonable amount of plant, inventory and distribution capital. CNH does not disclose segment capital employed in enough detail to calculate a clean Construction ROIC. That alone makes the portfolio problem harder for outside shareholders to measure.

Financial Services is healthier, but the late-cycle credit signals are genuine. At year-end 2025, receivables more than 30 days past due represented 3.1% of receivables, up from 1.9% a year earlier; by March 2026 the ratio was 3.5% versus 2.3% a year before, with South America identified as the principal source of deterioration. Q1 managed receivables were about $28.0 billion, with 71% retail and 29% wholesale. Financial Services earned $333 million in 2025, about a 12% return on average equity, before H1 2026 earnings weakened to $145 million. Credit is not in crisis, but this is exactly where a prolonged agricultural downturn would become more expensive.

Governance here is economically relevant, not boilerplate. The June 2026 10-Q states that Exor controlled 45.6% of CNH's voting power and could significantly influence dividends, director elections, mergers, asset dispositions, equity issuance and indebtedness. CNH had 1.238 billion ordinary shares plus 370.4 million loyalty-program special-voting shares outstanding. Exor's long-standing common-share block is roughly 30% of the economics; the loyalty arrangement effectively gives qualifying long-held shares an additional vote, magnifying that economic stake into near-veto-level voting influence. CNH also purchased $324 million of goods, principally engines, from Iveco in H1 2026 under post-demerger arrangements, although it said there were no significant direct transactions with Exor itself during the period.

The investment case turns on whether Agriculture can normalize near 11–12% EBIT margins without needing Deere-like pricing power. I think it can. CNH earned 10.5% in Agriculture as recently as 2024 despite an already falling cycle, while today's 5%-area margin includes unusually low production, tariffs and investment spending. I do not assume that 2023's peak profitability becomes normal. That produces a fair-value outcome far less spectacular than a “return to peak” thesis: roughly $14–16.50 a share in my base valuation against $13.48 today.

The qualitative portrait, then, is “cyclical-reversal candidate.” The cycle can repair faster than reported P/E suggests, and the balance sheet does not look distressed. Yet the stock's discount to Deere is largely structural, not merely cyclical. CNH must prove three things before that conclusion changes: a precision stack that generates visible recurring economics, Agriculture margins that normalize without excessive price concessions, and a rational answer to a Construction business earning low-single-digit EBIT margins.

Vertical History, Financial Record and Market Narrative

CNH's roots stretch through several of the oldest brands in farm machinery, but the listed company is a product of industrial consolidation rather than a conventional start-up or IPO. Fiat's agricultural-equipment assets, Case, New Holland and related machinery businesses had already been assembled through decades of mergers before Fiat Industrial and CNH Global were combined into the Dutch CNH Industrial structure in 2013. The resulting shares traded in both New York and Milan. There was no ordinary IPO in which CNH sold a new growth story for fresh capital; the listing was principally a merger/reorganization route through which owners of the predecessor groups received shares in the new entity.

That origin still matters. CNH was born with brands, factories, dealers, a finance business and an anchor shareholder already in place. Its central strategic problem was never finding product-market fit. It was allocating capital among a sprawling set of mature industrial franchises and deciding whether conglomerate scale created more value than focus.

The first stage, from the 2013 combination through 2021, was the diversified industrial era. CNH Industrial then included agricultural and construction equipment alongside the on-highway operations that eventually became Iveco Group. Results and revenue from this period are not comparable with current CNH. Any database series showing CNH revenue comfortably above the present $20-billion neighborhood before 2022 can be mixing businesses that current shareholders no longer own. The 2022 Iveco separation changed the object being valued. Iveco became an independent publicly listed company on January 1, 2022 through a Dutch-law demerger, and the current 10-Q still names the separation date.

The second important strategic move came immediately before that simplification: buying Raven Industries in 2021. Raven gave CNH application control, guidance, connectivity and autonomous-vehicle capabilities at a time when equipment makers were racing to turn precision technology into a higher-margin, more defensible layer above the iron. The long-term rationale was sound: a second-tier agricultural machinery company cannot let Deere own the digital layer. Some of the expected technology value did not mature as originally booked, though: CNH impaired $123 million of acquired Raven in-process R&D in Q4 2025. CNH also wrote down $62 million related to Monarch Tractor and other minority investments in the same quarter.

The third stage, 2022–23, was exceptionally favorable. The newly focused off-highway company entered a period of high crop prices, constrained machinery supply, strong farmer liquidity and unusually good pricing. Agriculture became the dominant source of industrial earnings, and 2023 represented the peak against which current results look dramatically depressed. The peak should be treated as an upper-cycle reference, not a sustainable earnings base.

The corporate structure was simplified further in late 2023 and early 2024. CNH announced the voluntary termination of its Milan listing and completed the move to a single New York Stock Exchange listing in January 2024; the NYSE ticker subsequently became CNH, replacing the older CNHI symbol. Current filings and IR releases now identify only “NYSE: CNH.” The simplification came with a share-repurchase authorization of up to $1 billion. Historical price and index series crossing that date therefore require care: ticker, listing venue and pre-/post-Iveco business perimeter all changed within a short span.

The fourth stage began as agricultural demand rolled over. By 2024 Agriculture net sales had fallen to $14.01 billion, with adjusted EBIT margin at 10.5%. In 2025 sales fell another 12% to $12.39 billion and margin to 6.2%. Construction went from $3.05 billion of sales and a 5.5% margin in 2024 to $2.96 billion and 2.3% in 2025. Adjusted Industrial EBIT more than halved to $663 million. CNH's 2025 adjusted EPS fell from $1.05 to $0.55.

The 2024–26 figures come directly from CNH's annual and second-quarter disclosures.

The business reason behind the table is more important than the arithmetic. Sales declined, but earnings declined much faster. In Agriculture the downturn hit production volumes and mix while CNH simultaneously tried to reduce dealer inventory. Manufacturing businesses with large plants and engineering organizations carry heavy fixed cost. A lost dollar of production strips out much more EBIT than a lost dollar of revenue would in a fully variable-cost model. Tariffs and persistent technology expenditure then sat on top of the volume deleverage.

The 2025 consolidated cost structure makes that visible. Cost of goods sold was $12.389 billion against $15.346 billion of industrial net sales, implying about a 19.3% industrial gross margin on that rough comparison, down from about 21.7% in 2024. SG&A increased 9.6% to $1.876 billion and R&D rose 10.9% to $1.025 billion despite the revenue contraction. Part of what looks like terrible operating leverage is deliberate: management did not try to protect trough EPS by stripping engineering expenditure to the bone.

Gerrit Marx's tenure should be read through this transition. He took over as the equipment cycle was already deteriorating and has emphasized operational quality, manufacturing discipline, reducing channel inventories, concentrating resources on Agriculture and maintaining technology investment. The test of his strategy will come after retail demand stops falling. Cost savings achieved while factories remain underutilized are difficult to distinguish from deferred spending; real evidence arrives when volume recovers and the incremental EBIT margin appears.

Cash flow tells a similarly cyclical story. Consolidated operating cash flow was $1.97 billion in 2024 and $2.54 billion in 2025 despite net income falling sharply. The headline operating-cash-flow/net-income ratio looks oddly strong: approximately 1.6 times in 2024 and 5.0 times in 2025. That ratio is a poor owner-earnings measure because consolidated cash flows include Financial Services receivable movements. Industrial free cash flow is the cleaner measure for the manufacturing company: negative $401 million in 2024, positive $513 million in 2025 and $150 million in Q2 2026.

The first half of 2026 also shows why one quarter's cash generation cannot be annualized mechanically. Consolidated operating cash flow was only $180 million as inventories absorbed $436 million. Property, plant and equipment plus intangible expenditure was $210 million while depreciation and amortization excluding operating-lease assets was $233 million. That relationship suggests current physical/intangible capital expenditure is near maintenance-level depreciation, not a huge new capacity build. My normalized owner-earnings model assumes roughly $450–500 million a year of maintenance capital expenditure, with another $100–200 million of genuinely discretionary or growth-oriented capital in healthier years. The split is an analyst estimate because CNH does not disclose “maintenance” and “growth” capex separately.

Balance-sheet analysis requires separating the two economic entities. At June 30, Industrial Activities had approximately $2.52 billion of net debt. Financial Services had about $20.83 billion of net debt, but that funding sat against a large financing-receivable book. Combining the two to say CNH has “$23 billion of net debt” and then dividing by industrial EBITDA would be economically nonsensical. The consolidated pension/post-employment liability was comparatively manageable at $332 million.

†Classification is based on CNH's supplementary segment balance-sheet presentation. The consolidated company had $1.868 billion cash and $596 million restricted cash.

The captive lender also affects credit ratings and liquidity. CNH reports a large committed-liquidity position, and its IR materials showed Moody's Baa2 with stable outlook, S&P BBB stable and Fitch BBB with negative outlook; Fitch's May 2026 change to negative cited the prolonged agricultural downturn and delayed recovery in CNH's financial profile. This is not a near-term solvency case, but prolonged low industrial profitability can make funding more expensive precisely when Financial Services needs cheap capital to support customer purchases.

The stock-market narrative has moved through the same stages. Investors rewarded the 2021–23 crop-income, pricing and supply-constrained upcycle; then discounted declining large-ag volumes and repeated earnings compression through 2024–25. During 2026 the emphasis started to move from “how low will earnings go?” toward “does 2027 recover?” That narrative shift explains why the stock can strengthen even while current EPS remains poor. A secondary market-data report showed the shares up roughly 11% from the August earnings release to early September after CNH raised the lower end of guidance.

Calling the current valuation historically “high” because the P/E exceeds 30 times would misread that history. The earnings denominator is at the bottom of the cycle. Calling CNH “cheap” because normalized earnings could be much higher would make the opposite mistake if the normalization assumes peak pricing, peak factory utilization or Deere-like technology economics. The correct valuation question is what CNH earns in an ordinary agricultural year.

Business Model, Moat, Governance, Industry and Cycle

Agriculture is the company. In 2025 it generated $12.39 billion of CNH's $15.35 billion industrial net sales and $772 million of segment adjusted EBIT. Construction added $2.96 billion of sales and just $68 million of adjusted EBIT. Segment totals exceed reported Industrial adjusted EBIT because corporate and other costs sit outside the two segment figures. Before central costs, Agriculture supplied essentially all the positive industrial segment profit.

The Agriculture business makes money from tractors, combines, hay and forage machinery, crop-production/application equipment, parts, technology and related services. Case IH and New Holland cover broad parts of the market; STEYR is a smaller European premium-oriented brand. The capital goods themselves create the installed base from which dealers can sell parts, service and upgrades. Financial Services then helps finance both retail purchases and dealer inventories. The resulting machine-dealer-finance relationship creates more customer persistence than the raw equipment sale alone.

CNH's cost base contains a heavy fixed component. Factories, tooling, engineering, product compliance, dealer support, software development and central functions do not shrink proportionally when farmers stop ordering $500,000-plus machinery. Raw materials, logistics and purchased components are more variable, while production labor lies somewhere between. This is why Agriculture's margin can move several hundred basis points on relatively modest changes in sales.

Production discipline creates a deliberate short-term cost. CNH is producing conservatively enough to bring dealer inventory down instead of pushing machines into the channel just to keep factories full. That reduces fixed-cost absorption today but improves the odds that future factory shipments reflect end-market demand, not dealer restocking. Reuters described the same strategy across CNH and peers during 2025, while CNH's own 2026 outlook explicitly says it will keep production low and reduce channel stock.

The requested $500 million dealer-inventory target comes with a caveat. The company has discussed the figure in management communications, but the 10-Q does not give a region-by-region table of dealer units and months of supply that lets an outside investor independently reconcile the target. Management's “last innings” description is a claim that can be tested only indirectly through dealer orders, Financial Services wholesale balances, reported production and future margin recovery. I would not award the full under-absorption benefit to normalized earnings until that bridge appears in results.

CNH's real moat is installed-base/channel scale plus brand and finance; precision software is still an unproven moat. Case IH and New Holland have been used by generations of farmers, and a farmer who already owns compatible implements, dealer relationships, parts inventories and trained operators faces friction in changing brands. A broad global manufacturing footprint also spreads engineering and sourcing costs over large volumes. Those advantages have survived bad cycles and qualify as real moats. They do not prevent share loss and are weaker than Deere's integrated North American ecosystem.

Precision agriculture is where that line becomes stark. CNH's FieldOps is frequently conflated with AGCO's PTx. They are separate competitive stacks. CNH obtained Raven to accelerate guidance, application control and automation; it later added capabilities in machine vision and GNSS, and FieldOps is the front-end digital environment intended to unify machine and agronomic information. Certain Raven technologies can serve mixed fleets, while CNH increasingly uses the acquired technology for factory-integrated Case IH and New Holland offerings.

The disclosure remains the problem. CNH does not report Raven/FieldOps revenue, recurring subscription revenue, gross margin, active-acre penetration or technology attach in a separate segment. Investors are left with no way to establish whether precision technology earns a much higher return than machinery. The 2025 Raven-related R&D impairment raises the evidentiary bar further. A good product portfolio can exist without being a financial moat; a financial moat appears when switching costs, recurring revenue, pricing or measurable share prove it.

Construction lacks the same defense. At 2.3% adjusted EBIT margin in 2025 and 1.7% in Q2 2026, the segment has little room for product mistakes, dealer incentives, warranty costs or tariffs. Q2 sales rose 12%, yet adjusted EBIT fell because production costs including tariffs outweighed the volume benefit. Management's 2026 plan focuses on manufacturing efficiency, quality and tariff offsets. There is no disclosed intention to divest the business.

Because CNH does not publish Construction capital employed, an exact segment ROIC is unavailable. A rough company-level industrial proxy is informative: taking Industrial equity as consolidated equity less Financial Services equity, then adding Industrial net debt, implies approximately $7–8 billion of industrial invested capital before more detailed eliminations. A roughly $0.5–0.6 billion 2026 Industrial adjusted EBIT outcome would generate only mid-single-digit after-tax returns on that proxy. A normalized $1.6–1.7 billion of EBIT would instead produce returns in the high teens. Construction at 2% margin almost certainly pulls the company toward the former outcome rather than the latter. This is an analytical estimate, not a company-reported ROIC.

The portfolio argument for retaining Construction is diversification and some shared technology, sourcing and distribution. The shareholder counterargument is opportunity cost: a company that says Agriculture and precision are its priority is still funding a low-return second segment against Caterpillar, Komatsu, Deere and lower-cost Asian machinery producers. I assign Construction a low valuation multiple rather than assuming management can transform it into a premium franchise.

Financial Services has a real strategic purpose. Captive finance helps dealers carry inventory and lets farmers transact with one ecosystem for machine, financing and service. In a downturn it also exposes CNH to the same customer twice: first through fewer machine purchases, then through credit deterioration. Year-end 2025 managed receivables were $28.6 billion, with 30% wholesale. The >30-day past-due ratio rose from 1.9% to 3.1%; Q1 2026 reached 3.5%, with CNH specifically identifying economic and environmental stress in South America.

The deterioration is material but not yet alarming. Financial Services earned $333 million in 2025 on average equity of roughly $2.8 billion, an ROE around 12%. H1 2026 net income fell to $145 million, reflecting lower portfolio volumes, yield effects and higher risk costs, particularly in Brazil. Retail originations also declined. A lender earning low-teens ROE with worsening delinquencies deserves roughly book value, not a large financial-sector premium.

The funding side needs watching. Financial Services had $21.7 billion of third-party debt at June and $22.6 billion of net financing receivables. The scale is economically reasonable for a captive lender but makes spreads and ratings relevant. A downgrade that raises funding costs can hurt both finance earnings and the attractiveness of subsidized equipment financing offered to dealers and farmers.

Governance is the other permanent element of the discount. The June 10-Q gives the clearest current number: Exor held 45.6% of CNH's voting power. CNH had 1,237,725,958 common shares and 370,432,786 loyalty special-voting shares outstanding. The loyalty program rewards qualifying continuously registered long-term shares with an additional vote, which turns Exor's roughly 30% ordinary economic interest into almost half of shareholder voting power.

Exor's 45.6% voting power is economically material to valuation. A hostile takeover or board change without Exor's cooperation is practically implausible. The generic acquisition premium often embedded in industrial stocks should not be capitalized into CNH. Buybacks also have a governance side effect: if Exor does not tender proportionally, retiring public shares can increase its economic and voting percentages further. Between December 2025 and June 2026 common shares outstanding declined by about 4.3 million, while H1 share purchases used $62 million.

Control does not automatically mean expropriation. Exor has a great deal of economic capital at risk and a long industrial horizon. The latest 10-Q said CNH had no significant direct transactions with Exor in H1 2026. The relevant issue is optionality: minority shareholders cannot force a portfolio separation, takeover or aggressive capital return if the controller prefers another path. Related-party links also exist across the wider portfolio. CNH purchased $324 million from Iveco in H1 under post-demerger arrangements, including a long-term engine-supply agreement; the filing identifies Stellantis, Ferrari and Iveco among Exor-related parties. Alessandro Nasi also holds roles across Exor-related industrial companies.

The agricultural machinery industry itself is mature and highly cyclical. Unit growth over decades is slower than software or semiconductors; value growth comes from price, greater machine productivity, replacement, farm consolidation and increasing technology content. The most attractive profit pools are large high-horsepower equipment, parts and service, precision/automation and captive financing. Smaller tractors and basic implements face greater fragmentation and price competition.

The cycle combines four forces. Commodity prices and farmer profitability set the willingness to invest; interest rates affect the cost of financing expensive equipment; dealer inventories determine whether retail demand becomes factory production; and technology/product cycles affect replacement. Large machines have long useful lives, so farmers can postpone purchases for a year or two when economics deteriorate. That makes orders much more volatile than planted acreage or food demand.

CNH's Q2 retail-demand statistics show a global downturn, not one weak market. North American tractors above 140 horsepower were down 17% year over year and smaller tractors down 16%; combines were down 7%. EMEA tractors fell 11%. South American tractors fell 8% and combines 29%. Asia-Pacific tractors grew 15%, but combines fell 48%. Agriculture's reported Q2 sales nevertheless remained near $3.3 billion because price and currency partly offset volume weakness.

The practical lag between farm economics and large-equipment demand is roughly several quarters, not contemporaneous. The crop-price and farm-income peak came before the deepest factory cuts; dealers first sell down inventories, farmers extend replacement intervals, then manufacturers reduce production. A reasonable underwriting assumption is six to eighteen months from a sustained improvement in row-crop economics to clearly stronger manufacturer earnings. That is an analytical rule of thumb rather than a company-reported statistical coefficient.

North America remains weak in precisely the products that matter most to margin: large tractors and combines. Headline U.S. farm income is a less useful signal than row-crop cash margins because government support and strong livestock income can lift aggregate farm income without making a corn or soybean operator eager to replace a combine. A February 2026 USDA forecast cited by Reuters expected U.S. net farm income of $153.4 billion, down 0.7%; I treat that figure as directional because I was unable to retrieve a newer September USDA farm-income release in the accessible source set.

South America appears later in its own reset. CNH explicitly blamed lower South American volumes in Q2, and the 29% collapse in combine demand is severe. Brazil also matters disproportionately to Financial Services credit deterioration. Subsidized agricultural-credit program timing can shift purchases between quarters, so a single Brazilian quarter is noisy; the combination of weak machinery units and higher delinquency/risk cost is more persuasive evidence of stress.

Europe looks closer to stabilization than to a strong rebound: tractors were still down double digits in Q2, while combines were nearly flat. Currency translation has become modestly helpful. Q2 Agriculture sales rose 1% reported while falling about 1% at constant currency; Construction grew 12% reported and 10% at constant currency. Full-year guidance incorporates roughly two percentage points of favorable currency translation. Investors should keep reported recovery separate from local-currency volume recovery.

Tariffs are now part of the production-footprint question. CNH builds across North America, Europe, Brazil and India and sources complex component chains globally. A tariff can hit imported raw material, a component, or an assembled machine, meaning localization and sourcing changes are more valuable than a one-time price increase. The official Q2 release says tariffs reduced Agriculture and Construction EBIT; the call-level estimate of an approximately 170-basis-point 2026 Agriculture burden, down from an earlier 210–220 basis points, implies mitigation has helped but has not removed the problem.

The cycle conclusion is asymmetric. Industry retail demand is already near trough levels, dealer inventory has been worked down for two years, and CNH is intentionally refusing to overproduce. That makes another enormous volume collapse less likely unless crop economics deteriorate sharply. A 2027 recovery is plausible. The evidence does not support assuming a powerful V-shaped recovery yet: North American large-ag units are still falling at double-digit rates, South American combines are deeply negative and credit metrics are worsening.

Horizontal Competitor Analysis

The useful comparison is three-cornered. Deere is the benchmark premium franchise. AGCO is the focused agricultural-equipment challenger with a deliberate mixed-fleet precision strategy. CNH is the larger full-line challenger with broader brand history, its own captive lender and a Construction business that dilutes returns. Caterpillar and Komatsu matter primarily for assessing Construction, not for the core agricultural thesis.

Current equity valuations illustrate why raw P/E comparisons fail.

Market values and reported P/E figures are current market-data snapshots and use each issuer's reported accounting EPS, so they are not cycle-normalized.

CNH's reported multiple is the highest in the table, yet its franchise is plainly not the best. That is the clearest illustration of the denominator problem. CNH's 2026 earnings are much further below normal than its share price. Deere also faces agricultural cyclicality, but its premium multiple carries a structural component: investors pay for superior dealer economics, precision penetration, aftermarket revenue and evidence that technology can defend machine pricing.

Deere became the industry's integrated ecosystem company. Its machinery, dealer, parts, telematics and farm-management architecture reinforce one another. In high-value North American row-crop farming, the farmer's decision increasingly concerns an operating system for the farm rather than an isolated tractor. The closed nature of that ecosystem can irritate mixed-fleet customers, but economically it raises switching friction and lets Deere capture more of the customer's lifetime spend.

AGCO became something different. Fendt gives it a premium machine franchise, Massey Ferguson and Valtra broaden the equipment base, while Precision Planting and the PTx/Trimble architecture attack the technology market without requiring the farmer's entire fleet to carry one OEM badge. That makes AGCO's precision thesis strategically coherent: a farmer who will not replace five competitor machines can still buy technology upgrades across those machines.

CNH sits in the middle. Case IH and New Holland give it far greater installed machine scale than a niche equipment maker, and Raven gives it a serious precision capability. The weakness is strategic legibility. Deere can say “buy our integrated system.” AGCO can say “upgrade the mixed fleet you already own.” CNH is simultaneously trying to make Raven technologies broadly useful and integrate them tightly into Case IH/New Holland through FieldOps. Hybrid strategies can work, but they must prove why the customer chooses them rather than simply offering most of the same features.

CNH deserves a permanent discount to Deere unless FieldOps/Raven proves a monetizable ecosystem. The burden of proof should be financial: recurring revenue, paid subscriptions, technology attach rates, acreage or machine penetration, measurable parts/service uplift or superior retention. CNH currently does not disclose enough of those metrics to underwrite a software-like multiple.

Dealer networks reinforce the difference. Deere's strongest position is in North American large agriculture, where a dense dedicated dealer base supports uptime, parts and trade-ins on machines for which downtime during planting or harvest is extremely expensive. CNH has substantial Case IH and New Holland distribution worldwide, but two brands and more variable regional dealer strength create less uniform economics. AGCO's network is smaller in North America but Fendt has strengthened its premium position, particularly outside the U.S.

The difference appears in pricing power. Deere's technology and high-value large-ag mix support a stronger ability to protect price even when units fall. CNH achieved favorable pricing in Q2 2026, which helped offset volumes, but Agriculture margin still fell from 8.1% to 5.2%. Pricing helps. It is not enough to overwhelm under-absorption, tariffs and mix.

Aftermarket is similarly important but poorly disclosed on a directly comparable basis. CNH does not provide an investor-friendly aftermarket attach rate that can be put beside Deere's economics. So I do not credit CNH with Deere-equivalent lifetime customer monetization in the valuation. The absence of evidence is not evidence of zero aftermarket value; Case IH and New Holland clearly have meaningful parts businesses. It is evidence against paying a premium multiple for an unmeasured advantage.

Returns through the cycle tell the same story. CNH Agriculture generated a 10.5% adjusted EBIT margin in 2024, 6.2% in 2025 and is guided to 5.0–5.5% in 2026. The peak was much higher. The volatility shows the franchise can make excellent money with full factories but gives much of it back when large equipment demand contracts. Deere's premium should be read partly as a lower required “normalization haircut,” not merely as market enthusiasm.

AGCO's valuation poses the more relevant question for CNH. AGCO lacks CNH's construction drag and controlling shareholder, but is smaller and has its own cyclical and execution risks from its precision investments. CNH's advantages are broader global scale, two major agricultural brands and a larger captive-finance ecosystem. AGCO's advantages are strategic focus and a cleaner mixed-fleet technology identity. At similar normalized agricultural profitability, I would give AGCO a modest governance/portfolio premium unless CNH fixes Construction.

Construction widens the comparison to Caterpillar and Komatsu. CASE and New Holland Construction compete in a market where Caterpillar's dealer network, parts economics and product breadth are much stronger, while Komatsu has global scale in heavy equipment. So CNH's 1–2% current segment margin is not simply “cyclical Caterpillar at a discount.” The segment occupies a weaker competitive niche.

Keeping Construction can make sense only under one of three economic outcomes: management lifts normalized margins materially; the segment provides enough shared fixed-cost and dealer benefits to Agriculture to justify poor stand-alone returns; or a future owner values the assets more highly than public markets do. Current disclosure establishes none conclusively. My valuation assumes only a 4.5% normalized margin and a low multiple, rather than embedding a heroic turnaround.

The three-way precision contest is the most consequential long-term comparison. Deere should win where farmers value an integrated, factory-installed, highly automated system and accept vendor lock-in. AGCO/PTx has the clearest proposition where farmers operate mixed brands and want retrofit economics. CNH can win customers who already prefer Case IH or New Holland and want technology integrated with the machine, while Raven gives it some retrofit reach beyond the installed base.

My ranking differs depending on the market. Deere is first in integrated large-ag economics. AGCO has the most interesting open/mixed-fleet challenger architecture. CNH is credible but currently third in demonstrated technology monetization. That weakness is structural until proven otherwise. The cycle may close part of CNH's valuation discount; technology disclosure and adoption are required to close the rest.

Current Fundamentals, Valuation and Expectations

The latest four-quarter picture is a trough transitioning into stabilization, not a recovery already underway. Full-year 2025 revenue fell 9% to $18.10 billion and adjusted EPS almost halved to $0.55. Q1 2026 was especially weak: Industrial adjusted EBIT was negative $45 million, Agriculture margin only 1.0%, and industrial free cash flow absorbed $589 million. Q2 improved sharply from that sequential low, with consolidated revenue of $4.80 billion, Agriculture margin of 5.2% and $150 million of industrial free cash flow.

The comparison with Q2 2025 remains poor underneath revenue. Agriculture sales of $3.277 billion were essentially flat, but EBIT fell from $263 million to $170 million. Construction sales increased from roughly $0.77 billion to $0.87 billion, yet EBIT margin fell to 1.7%. Financial Services Q2 net income declined to $71 million from $87 million. The business has stopped shrinking in headline sales faster than it has stopped shrinking in earnings.

The guidance revision was meaningful. In February CNH expected Agriculture sales down 5% to flat, Construction roughly flat and adjusted EPS $0.35–0.45. After Q2 it expected Agriculture roughly flat, Construction up 5–10%, industrial free cash flow $200–400 million and EPS $0.41–0.46. Management did not declare the cycle recovered; it narrowed the range toward the better part of the original downside scenario.

The August release explicitly describes guidance as narrowed to the higher end of previous ranges.

The biggest remaining margin issue is Agriculture. Q2's year-on-year 290-basis-point margin compression came from several places, not one. South American volume weakened, North American and EMEA mix deteriorated, tariffs rose, SG&A and R&D were higher and JV income fell. Pricing was favorable. This matters for normalization: pricing and tariff mitigation can recover sooner than factory utilization, while R&D may remain elevated indefinitely if CNH intends to narrow the precision gap.

The 170-basis-point full-year tariff estimate is unusually large relative to a 5.0–5.5% Agriculture margin. The implication is that 2026 underlying operational improvement is already offsetting part of the tariff burden; otherwise margin would be materially below 2025's 6.2%. That is encouraging, but the tariff environment remains policy-sensitive, and CNH's geographic footprint prevents it from solving the problem through one localization decision.

Financial Services is a second pressure point. Year-end past dues above 30 days increased 120 basis points year on year, then reached 3.5% in Q1. CNH says Brazil is a major source of risk cost. Wholesale exposure was 30% of the managed portfolio at year-end and 29% in Q1, so there is no disclosed evidence that dealer floor-plan exposure is ballooning as CNH reduces channel stock. That is reassuring.

The market is now trading the slope of 2027 earnings rather than the absolute level of 2026 earnings. That is visible in the gap between the headline valuation and the normalized one. At $13.48, the latest $0.41–0.46 guidance equals 29–33 times adjusted EPS. A business expected to earn only $0.44 indefinitely would not justify today's price. The share price already embeds an earnings recovery.

The 2026 P/E is a trough artifact; the normalized multiple is the relevant one. My central normalization uses neither the 2023 peak nor 2026 trough:

§2023 values are rounded continuing-operations peak references; they are deliberately not used as the base valuation. 2025 and 2026 anchors are from CNH's current primary disclosures.

The mid-cycle Agriculture sales assumption represents roughly a 21% recovery from 2025, yet remains about 17% below the 2023 peak. The 11.5% margin sits only one percentage point above the depressed 2024 result and well below peak profitability. Construction receives only a 4.5% margin. These assumptions require a real industry normalization but do not require a return to 2023 economics.

Using those inputs, Agriculture contributes about $1.73 billion of adjusted EBIT and Construction about $0.15 billion. After approximately $0.20 billion of unallocated corporate costs, normalized Industrial EBIT is around $1.67 billion. Applying normalized industrial interest and tax, then adding roughly $350 million of Financial Services net income, gives approximately $1.4–1.45 billion of normalized group earnings and $1.15–1.20 per diluted share depending on the future buyback-adjusted share count.

At today's price, that is roughly 11.5 times mid-cycle EPS. That multiple is cheap relative to Deere's premium franchise but only modestly cheap for a cyclical manufacturer carrying weak Construction assets and a controller with 45.6% voting power. The valuation discount is doing real work. It is not a free lunch.

Cash-flow passthrough requires special treatment. A mechanical five-year consolidated operating-cash-flow/net-income ratio is inappropriate because the business perimeter changed with Iveco in 2022 and the continuing company consolidates a lender. In the clean recent years, 2024 CFO/net income was about 1.6 times and 2025 about 5.0 times, but Industrial FCF was negative $401 million and positive $513 million respectively. The huge difference comes from financing receivables and working capital. In valuation I default to normalized industrial owner earnings, not consolidated CFO.

Maintenance capex is not separately reported. H1 2026 PP&E/intangible spending of $210 million versus $233 million of relevant D&A provides the best current anchor. I estimate annual maintenance expenditure at $450–500 million. Because most of CNH's R&D is expensed through the income statement, owner earnings do not require subtracting the entire technology budget again. On my mid-cycle model, owner earnings are around $1.25–1.35 billion, or roughly $1.05–1.10 per current-equivalent share after allowing for maintenance capital and normalized working capital. At $13.48 that corresponds to an owner-earnings yield around 8%, materially more informative than the 2026 P/E.

A sum-of-the-parts check reaches a similar answer. I value the lender around book value because Financial Services earns approximately low-double-digit ROE but credit metrics are deteriorating. I value the Industrial business on normalized EBIT, not current EBIT, and subtract Industrial net debt and pension obligations. Construction receives a substantially lower multiple than Agriculture.

†Price return before dividends. ‡Approximate midpoint CAGR plus an assumed modest dividend contribution; outcomes are valuation scenarios, not forecasts.

This scenario analysis is part of a research framework and is not investment advice.

The conservative case assumes Agriculture recovers from trough but never regains 2024's margin sustainably. That can happen if pricing erodes, precision spending stays high and factory utilization remains mediocre. The base case requires dealer destocking to finish, large-ag demand to recover over 2027–28 and tariff/cost pressure to become manageable. The optimistic case requires something closer to structural improvement: stronger technology attach, much better utilization and material Construction repair.

Historical valuation calls for restraint. A precise percentile calculation would create false accuracy because the 10-year history crosses the Iveco demerger, dual-to-single listing change, ticker change and an agricultural super-cycle. The meaningful post-demerger history is short. Today's 31-times trough adjusted EPS sits at an optically high point, while the estimated 11–12-times normalized earnings multiple sits in the ordinary range for a second-tier cyclical machinery company.

Peer valuation supports a discount, not convergence to Deere. Deere's larger installed base, premium North American dealer economics, precision ecosystem and parts economics justify a higher normalized multiple. CNH should close some of the current gap as earnings recover, but I do not model the gap disappearing. The valuation difference is a franchise judgment, not merely a cyclical trade.

The expectation gap centers on four numbers. Agriculture margin needs to move above 5% without a price-led demand problem; dealer inventory needs to finish declining so production can at least match retail; Financial Services past dues need to stabilize; and 2027 retail-industry guidance needs to turn positive. A quarter with flat retail demand but rising production could produce unusually good EBIT because of fixed-cost absorption, yet investors should distinguish that from true end-market recovery.

The next earnings release has not been formally confirmed on CNH's IR calendar as of the research cutoff. Two market calendars place Q3 results around November 6, 2026, while another estimates November 9; I treat November 6 as the working date, explicitly unconfirmed until CNH announces it.

The margin-of-safety test is less favorable than the normalized P/E first suggests. Current $13.48 trades above my $9.5–10.5 conservative fair value, so there is zero discount to that downside valuation.

The most fragile base assumption is the 11.5% normalized Agriculture margin. Reducing it to 70% of the assumption, about 8.1%, cuts normalized Industrial EBIT by roughly $0.5 billion. Running that lower EBIT through the same SOTP framework reduces base value to approximately $9.5–10 per share. This sensitivity is the main reason the stock cannot be called deeply undervalued just because 2026 is a trough.

If earnings stayed flat at the roughly $0.435 midpoint of 2026 guidance for three years, a constant share price would leave shareholders with little more than the dividend, under 1% a year at the current $0.10-equivalent annual payout. If the market instead applied a normal 12–14-times machinery multiple to unchanged $0.435 earnings, terminal value would fall toward $5–6 a share. Either interpretation produces a return below a reasonable long-duration government-bond hurdle. There is no margin of safety at this buy price under a three-year no-recovery case.

Margin-of-safety sufficiency verdict: none.

At $13.48, the stock is near my base hold zone, not my margin-of-safety buy zone.

Risks, Catalysts, Tracking and Cross-Synthesis

The highest-probability permanent-loss risk is a false 2027 recovery. I assign medium-to-high probability and high impact. The transmission path is straightforward: row-crop profitability remains weak, North American large tractors and combines keep falling, South America fails to recover, dealer inventories take longer to normalize, and CNH cannot lift factory utilization. Agriculture then settles closer to an 8–9% normal margin than the 11.5% in my base case. The observable indicators are >140-horsepower North American tractor retail, combine demand, production relative to retail and Agriculture EBIT margin. Q2's -17% large-tractor and -29% South American combine figures show that this risk is not theoretical.

The second risk is a permanent precision-agriculture disadvantage. Probability is medium; long-run impact is high. Deere can keep increasing the value of its integrated machine-data-service stack while AGCO/PTx becomes the preferred mixed-fleet retrofit architecture. CNH might then be forced to use FieldOps and Raven capabilities to protect machine share rather than monetize them as high-margin incremental products. The warning signs are continued absence of recurring-revenue disclosure, further Raven-related impairments, weak technology attach or evidence that CNH must discount technology to sell iron. The share-price effect would appear through both a lower normalized margin and a permanently lower multiple.

Financial Services credit is the third. Probability is medium, impact medium to high. A >30-day past-due ratio rising from 1.9% to 3.1% at year-end and to 3.5% in Q1 is already a deterioration. If Brazil remains weak and North American farm economics worsen, credit-loss provisions rise, captive-finance earnings fall and external funding spreads can widen simultaneously. A 4–4.5% past-due ratio would deserve close scrutiny; a sustained move above 5% would change my credit view materially.

Construction is a slower capital-loss mechanism. Probability that the segment remains subpar is high; impact on the whole group is medium. A business earning 1–3% EBIT margins while competing with Caterpillar, Komatsu, Deere and lower-cost manufacturers can consume management effort and capital without generating a sufficient return. The observable test is simple: if Construction cannot sustain at least a mid-single-digit margin after the cycle normalizes, my 4.5% base margin is already generous and its strategic ownership should be questioned.

Tariffs are medium-probability and medium-impact because the cost can be partly mitigated. The estimated 170-basis-point Agriculture burden is large, but CNH has pricing, sourcing and localization options. Permanent damage occurs if tariffs force CNH to choose between losing share through higher prices and accepting structurally lower margins. Agriculture price realization, tariff-cost commentary and the gap between reported and constant-currency sales provide the best early indicators.

Governance is low-probability as an acute shock but structurally important. Exor's 45.6% voting power can block or heavily influence any major strategic transaction. The loss mechanism is opportunity cost: minority holders may never receive a takeover premium or may see capital retained in weak assets longer than they prefer. A related-party transaction on non-arm's-length terms would raise the impact sharply; the current filing says no significant direct Exor transactions occurred in H1, which is reassuring.

Positive catalysts over the next twelve months are unusually concrete. Agriculture margin above guidance while retail demand remains weak would show that tariff mitigation and cost actions are working. Completion of the $500 million dealer-stock reduction would allow production to converge toward retail and restore absorption. A positive 2027 global agricultural-equipment outlook would convert the current market narrative into measurable orders. Stabilization in Brazilian delinquencies would remove a second-cycle concern. Buybacks conducted below normalized value would be accretive, although they also increase the governance concentration if Exor does not sell proportionally.

Negative catalysts are the mirror image but more damaging because the stock already anticipates recovery: another 2026 or 2027 guidance reduction, no improvement in large-ag retail by early 2027, Agriculture margin slipping below 5%, a Financial Services past-due ratio above 4%, tariff cost returning toward the earlier 210–220-basis-point estimate, or continued Construction margins around 2%.

§Market-calendar estimate, not yet company-confirmed at the research cutoff. Current operating and balance-sheet indicators come from CNH's Q1/Q2 filings.

The dashboard needs to be read as a system, not as ten independent signals. Retail units turn first. Dealer inventory then determines how quickly retail improvement reaches factory production. Production drives fixed-cost absorption and Agriculture margin. Financial Services tells investors whether the downturn has caused balance-sheet damage while they wait. Industrial free cash flow confirms whether the accounting recovery actually reaches shareholders.

The most likely positive sequence is not explosive sales growth. It is retail demand moving from double-digit decline toward flat, dealer destocking ending, factory production rising modestly, and Agriculture margin improving several hundred basis points on relatively little revenue growth. That is why CNH can produce strong earnings growth in 2027–28 without returning to 2023 unit demand.

The strongest negative sequence would be the opposite. If retail remains down but management raises production to defend factory margin before dealers are clean, earnings can improve briefly while channel risk rebuilds. Investors should distrust a margin recovery that is not accompanied by evidence of normalized dealer inventories and sell-through.

Looking vertically, CNH has proven one capability very clearly: it can operate a large global agricultural machinery platform through multiple cycles and earn excellent profits when demand and factory utilization are strong. What it has not proven is that those peak profits are protected by a technology and aftermarket moat strong enough to survive a deep industry contraction. The 2024-to-2026 margin path argues otherwise.

Part of the historical success came from the cycle. The 2022–23 combination of high farm liquidity, supply constraints and pricing power benefited every large farm-machinery OEM. CNH deserves execution credit for capturing it, but that period is weak evidence that 15%-plus Agriculture margins are structural. The 2025–26 downturn is a better stress test of moat quality.

Management capability is becoming more important as the cyclical tailwind disappears. Maintaining R&D above $1 billion in 2025 while earnings collapsed was painful for current EPS but rational if the company truly intends to narrow the technology gap. The capital-allocation question is whether the same discipline will be applied to Construction. Continuing to fund a 2%-margin business indefinitely while claiming strategic focus on Agriculture would be inconsistent.

Horizontally, CNH's competitive advantage is breadth without premium dominance. It possesses more machine and dealer scale than a niche challenger, two globally recognized agricultural brands, a sizable captive lender and credible precision assets. Deere has stronger integrated economics. AGCO has a cleaner mixed-fleet technology narrative. CNH's niche is the scaled second full-line supplier that can offer most of the capabilities of the leader at a lower implied franchise valuation.

My central judgment is that the cycle is more likely to improve before the franchise discount disappears. That distinction explains both the opportunity and the limited margin of safety. Investors do not need CNH to become Deere for earnings to rebound. They do need substantially better evidence before paying Deere's multiple.

At one year, the decisive variables are dealer inventory, Agriculture margin, tariff mitigation and Financial Services delinquencies. At three years, they are normalized Agriculture margin, precision attach/monetization and Construction's future. At five years, the central issue is whether CNH has built a defensible agricultural technology ecosystem or remains primarily a cyclical iron manufacturer whose digital products are required merely to stay competitive.

The market is probably underestimating how fast earnings can improve when production again matches retail. Fixed-cost absorption can create a sharp margin recovery before end-market sales return to prior peaks. The market may simultaneously be overestimating the quality of those recovered earnings if it assumes they deserve the same multiple as Deere. Both statements can be true.

Bull reasons:

• 2026 guidance has already moved from $0.35–0.45 to $0.41–0.46 adjusted EPS despite continued weak large-ag demand, evidence that cost and mix outcomes are better than the February downside case.
• Agriculture is being valued at roughly 11–12 times my $1.15–1.20 mid-cycle EPS rather than the meaningless 31-times trough EPS.
• Deliberate channel destocking and low production make eventual normalization of factory absorption a powerful earnings lever without requiring a return to 2023 revenue.
• Industrial net debt of roughly $2.5 billion is manageable relative to normalized earnings capacity, while Financial Services debt is backed by its receivable portfolio rather than industrial operations.
• R&D spending has been maintained through the trough, giving Raven/FieldOps a chance to improve the franchise rather than merely harvesting legacy machinery economics.

Bear reasons:

• Agriculture margin fell to 5.2% in Q2 despite flat reported sales, showing weaker pricing/absorption resilience than a premium franchise.
• Financial Services >30-day delinquencies rose from 1.9% to 3.1% during 2025 and reached 3.5% in Q1 2026, so credit deterioration is moving in the wrong direction.
• Construction earned only 2.3% EBIT margin in 2025 and 1.7% in Q2 2026, with no disclosed plan to exit the low-return business.
• CNH does not disclose enough revenue, recurring income or attach data to prove that Raven/FieldOps has economics comparable with Deere's precision ecosystem.
• Exor controls 45.6% of voting power on roughly 30% economics, limiting change-of-control optionality and justifying some governance discount.

Pre-mortem: first script. Suppose the shares are down 50% by 2029. Corn and soybean economics remain weak through 2027, North American large-tractor demand falls another 10%, and South American demand fails to rebound. CNH finishes dealer destocking but has too little retail demand to refill the channel. Agriculture sales normalize around $13.5–14 billion and margin only 7%, not 11.5%. Brazilian credit stress pushes Financial Services delinquencies above 5%, reducing lender earnings toward $250 million. The market concludes that $0.65–0.75 is normalized EPS rather than a trough and assigns 9 times earnings. A $6–7 share price becomes entirely plausible.

Second script. By 2028 Deere's integrated autonomy/precision stack and AGCO's PTx mixed-fleet retrofit strategy take most of the industry's high-margin technology spend. CNH keeps machine share by bundling Raven/FieldOps capabilities at low incremental prices. Agriculture recovers to $15 billion of sales but margin stalls at 9–10%; Construction remains at 2–3%. Investors abandon the idea of a technology re-rating and hold the equity at roughly 10 times $0.90–1.00 normalized EPS. The stock trades around $9–10 even though the agricultural cycle itself has recovered. That would establish the discount as structural.

Final research conclusion: CNH is a substantially better business than its 2026 earnings suggest and a meaningfully weaker franchise than a simple “second-largest farm-equipment maker” description implies. The agricultural cycle is close enough to trough that normalized earnings should be used for valuation, and a return to roughly 11–12% Agriculture margins could more than double earnings from the 2026 trough without restoring the 2023 peak. The $13.48 price, though, already discounts part of that recovery. My base value of $14–16.50 leaves some upside but not enough to compensate a new buyer for the $9.5–10.5 conservative outcome.

Construction, precision disclosure and Exor control keep me from assigning a premium multiple. Financial Services adds earnings and customer support but has begun showing genuine credit-cycle stress. The evidence supports owning CNH as a cyclical exposure at the right price, rather than treating it as a lower-priced substitute for Deere.

A better entry point would require either a lower share price or harder evidence that my normalized assumptions are too conservative. Agriculture sustaining more than 8% margin while dealer inventories reach management's target, North American large-ag retail turning positive, and Financial Services delinquencies falling back below 3% would justify raising normalized earnings. Conversely, Agriculture remaining below 7–8% after retail demand recovers would invalidate the core normalization thesis.

【Company-profile scores】

• Fundamental quality: medium
• Growth: medium
• Moat: medium
• Financial soundness: medium
• Management credibility: medium
• Valuation attractiveness: medium
• Risk level: medium
• Suitable investor type: cyclical

【Investment rating】

• Rating: Hold
• One-line thesis: Trough earnings should recover, but $13.48 already prices part of normalization while precision, Construction and Exor control warrant a lasting discount.
• Ideal buy price: see the required line below.
• Acceptable hold price: $12.50–17.50, roughly the ±15% neighborhood around the $14–16.50 base-value range.
• Clearly overvalued price: $25.90 and above, more than 10% above the top of the $21–23.50 optimistic valuation.
• Current-price classification: acceptable hold.
• Whether to wait for a better price: yes for a new position. The preferred trigger is $8.40 or below, or alternatively materially stronger fundamentals that raise the conservative value before the share price rises.
• Target holding horizon: 3–5 years.
• Expected annualized return: approximately -9% in the conservative case, +5% in the base case and +19% in the optimistic case over roughly three years, including a modest dividend assumption.
• Max-loss risk: approximately 50–55% if the 2027 recovery fails, normalized Agriculture margin settles near 7%, Financial Services credit losses rise and the stock receives only a 9-times normalized earnings multiple.
• Reassessment-trigger signals: Agriculture adjusted EBIT margin above 8% for two consecutive quarters after dealer destocking; North American >140hp tractors and combines turning positive year on year for two quarters; Financial Services >30-day past dues above 4.5%; Industrial net debt above $3.0 billion with negative full-year FCF; or Exor voting power moving above 50%.

【Ideal Buy Price】7.50–8.40 USD

Basis: approximately 20% or more below the $9.5–10.5 conservative fair-value range. The opportunity cost of waiting is missing an early cyclical re-rating if 2027 orders improve faster than expected; that is preferable, in my view, to paying today for a recovery that has not yet appeared in retail units.

【Valuation Range】

• current: 13.48 (close as of 2026-09-21)
• bear (conservative · ideal buy zone): [7.50, 8.40]
• base (fair · acceptable hold zone): [12.50, 17.50]
• bull (optimistic · above the clearly-overvalued line): [25.90, 28.00]

Research uncertainties: the most material blind spot is dealer inventory. CNH's accessible primary filings do not publish a consistent unit and months-of-supply bridge by product and region, so the $500 million target cannot be reconciled independently. Second, precision-agriculture revenue, margins, recurring revenue and attach rates are undisclosed; this prevents a proper software-style valuation. Third, Construction capital employed is not separately disclosed, so its ROIC can only be inferred from margins and group capital. Fourth, the approximately 170-basis-point tariff estimate and the $500 million dealer-inventory target come from management's earnings-call communications rather than the tables in the 10-Q/release, limiting independent reconciliation. Fifth, CNH had not formally announced the Q3 2026 reporting date at the research cutoff; November 6 is a market-calendar estimate.

Source hierarchy: the core financial work uses CNH's February 17, April 30 and August 3, 2026 company releases and the latest SEC 10-Q filed under CIK 1567094. The balance-sheet and governance conclusions use the June 30 10-Q, including its related-party note and exact 45.6% Exor voting-power disclosure. Market prices use the September 21, 2026 market snapshot. Credit context uses CNH's ratings page and Fitch's May 2026 action. Reuters is used only where it adds contemporaneous cycle/context not cleanly tabulated in the company filing, particularly industry destocking and the February USDA farm-income forecast.

Other tickers mentioned

• DE.US: Deere is the premium agricultural-equipment benchmark and the principal reference for integrated precision agriculture and dealer economics.
• AGCO.US: AGCO is the closest listed agricultural challenger and the owner of the PTx mixed-fleet precision strategy.
• CAT.US: Caterpillar is a benchmark for the economics CNH's Construction segment fails to approach.
• 6301.TSE: Komatsu is a major global construction-equipment competitor relevant to CNH's low-margin Construction business.
• 6326.TSE: Kubota is a secondary agricultural-equipment reference, particularly in smaller tractors and international markets.
• VMI.US: Valmont is a secondary reference for technology-enabled farm infrastructure and irrigation economics.
• RACE.US: Ferrari is cited as another Exor-controlled/influenced portfolio company relevant to CNH's governance context.
• STLA.US: Stellantis is another major Exor portfolio company and a related party identified in CNH's filings.

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.